What's New - Page 1

Author Guidelines Editorial Board About Us Contact Us Advertise Subscribe Issue Archive

RSS | Login | Register

What's new in hepatology: Triple therapy for hepatitis C

Christin Giordano, MPAS, PA-C February 23, 2012

Combining one of two newly approved oral agents with traditional medications offers hepatitis C patients better outcomes with shorter therapy.

What's new in lung cancer:  Screening, staging, targeted therapies

Michele Taffaro-Neskey, PA-C December 09, 2011

Chemotherapy damages both normal cells and tumor cells, but newer agents target specific biomarkers to inhibit cancer growth and progression.

What's new in emergency medicine : The utility of bedside ultrasonography

Clare Scott, PA-C October 20, 2011

Bedside ultrasonography has advanced the practice of emergency medicine, allowing physicians to establish prompt diagnoses and even improve patient outcomes.

What's new in multiple sclerosis treatment:  First oral drug, new antibody therapies

Teresa Frohman, PA-C, Megan Orchard, PA-C; Paula Hardeman, PA-C; Daniel L. O’Donoghue, PA-C, PhD August 18, 2011

A number of revolutionary new treatments for multiple sclerosis—including the first oral treatment, antibody therapies, and agents that may be able to regulate immune function—are currently being developed.

What's new in Alzheimer disease:  Biomarkers and gene mutations as aids for detecting AD early

John K. Grandy, MS, RPA-C June 16, 2011

New discoveries in neurogenetics and proteinopathies may allow Alzheimer disease to be detected in patients even before symptoms manifest.

What's new in sexual health:  CDC proposes new guidelines for the treatment of STDs

Patricia Jennings, DrPH, Laura Bachmann, MD, MPH April 19, 2011

The authors review the recent changes made in December 2010 to the Centers for Disease Control and Prevention guidelines for sexually transmitted diseases.

What's new in atrial fibrillation: Is dronedarone more effective than amiodarone?

Reamer L. Bushardt, PharmD, PA-C, Kelly W. Jones, PharmD, BCPS February 17, 2011

The authors compare the risks and benefits of two drugs used to treat patients with atrial fibrillation.

What's new in fracture prevention:  New osteoporosis drug improves  patient adherence

Kelly W. Jones, PharmD, BCPS, Reamer Bushardt, PharmD, PA-C December 20, 2010

Denosumab is the latest monoclonal antibody used to help prevent fractures and provides a number of new benefits.

What's new in minimally invasive surgery:  Robotic technology speeds recovery and improves outcomes

Alexandra Godfrey, MS, PA-C October 21, 2010

A new robotic surgery technique offering surgeons greater flexibility and precision decreases the patient's recovery time and risk of complications.

What's new in plastic surgery

Allison Hanley, MHS, PA August 19, 2010

Juvéderm, a new hyaluronic acid dermal filler with a smooth consistency and improved longevity, reduces wrinkles and folds.

What's new in military medicine: The ancient art of acupuncture is new again

Captain Trevor Ambron, MPAS, PA-C, USAF June 17, 2010

The modern-day equivalent of an ancient pain-relieving technique is helping injured troops without the side effects of narcotics.

What's new in breast oncology

Kathleen L. Connery, PA-C, MPAS April 16, 2010

Genetic profiling with the 21-gene RT-PCR assay improves predictions for risk of 10-year recurrence and response to chemotherapy.

What's new in diabetes: A1C assay emerges as a diagnostic test for diabetes

Karen A. Beer, PA-C, RD, CDE February 19, 2010

A committee of international experts recommends use of the A1C assay as the new standard diagnostic test for diabetes.

What's New in HIV/AIDS: Treatment Immune reconstitution inflammatory syndrome (IRIS) can complicate management of patients on antiretroviral therapy.

Daniel L. O’Donoghue, PA-C, PhD, Tara Gleaves, PA-C, MHS; Michelle R. Salvaggio, MD, FACP December 10, 2009

What's new in HIV AIDS treatment? Immune reconstitution inflammatory syndrome is associated with recovering immune status and can make patients susceptible to infection.

Benefits and harms of widespread PSA test use still unclear

Timothy Quigley, MPH, PA-C October 22, 2009

Despite the publication of the preliminary results of two studies and the update of two sets of guidelines, the benefits of prostate cancer screening are still controversial.

Best treatment of nonhealing and problematic wounds

Erich Fogg, PA-C, MMSc August 27, 2009

The latest wound-care modalities focus on stimulation of dermal growth and angiogenesis, new dressings, and specialized treatment centers.

A simple new blood test for allergy triggers

June 16, 2009

What's New in ... Allergy testing

Meaningful progress in colon cancer therapy options

Maura Polansky, MS, PA-C; Alicia C. Ross, MPAS, PA-C April 10, 2009

What's new in colorectal cancer treatment includes new chemotherapy options for metastatic disease and individualized therapies that increase efficiency, reduce side effects, and contain costs.

ACI of the knee for patients with cartilage injuries

Stephanie L. Stradley, PA-C February 12, 2009

What's New in ... Orthopedics

Treating vitiligo and psoriasis with the excimer laser

Bethany Brubb, MPAS, PA-C December 01, 2008

What's New in ... Dermatology

Statin therapy works for patients who have type 2 diabetes

Kenneth E. Korber, PA, PhD(c) October 01, 2008

What's New in ... Diabetes management

Compression-only CPR: Bystanders can still save lives

Timothy W. Ferrarotti, DHSc, PA-C August 01, 2008

What's New in ... Emergency medicine

Gastroenterology: 1987 and 2007

Richard Davis, JR, PA-C December 01, 2007

To commemorate JAAPA's 20th anniversary year, we have published a series of artices that highlight the changes that have occurred in the practice of medicine and surgery between 1987 and 2007.